Filing Flows

Filing Flows › Hims & Hers Health (HIMS) › Q2 2025

Hims & Hers Health (HIMS) Q2 2025 earnings results (second quarter 2025)

10-Q filed Aug 4, 2025

Hims & Hers Health (HIMS) reported revenue of $545M for the second quarter 2025 (Q2 2025), +73% from a year earlier and -7% from the quarter before. Operating margin was 4.9%, net earnings $42.5M (7.8% of revenue).

Revenue$545M
Year over year+73%
Quarter over quarter-7%
Operating margin4.9%
Net earnings$42.5M

Hims & Hers Health, Q2 2025: revenue $545M (+73% year over year), operating margin 4.9%, net earnings $42.5M, operating cash flow −$19.1M. The chart follows the revenue to costs, profit and cash.

Q2 2025AmountQ/QY/Y
Revenue$545M-7%+73%
Gross profit$416M-3%+62%
Operating profit$26.7M-54%+142%
Net earnings$42.5M-14%+220%
Operating cash flow−$19.1M-118%—

What changed

Revenue was $544.8M in Q2 2025, up 73% year over year and down 7% from the previous quarter.

Gross margin was 76.4%, down 4.9 points from a year earlier. Operating profit was $26.7M, a 4.9% margin (up 1.4 points year over year). Of the extra revenue versus a year earlier, 7% reached operating profit, above the 3% margin then. Operating expenses grew 59% against revenue growth of 73%. The fastest-growing cost line was General & admin (+66%). Net earnings were $42.5M, up 220% year over year. The effective tax rate was -29.4%.

Operating cash flow was −$19.1M. Non-cash charges added back $10.5M of depreciation and amortization and $35.7M of share-based compensation. Working capital and other items used $107.8M. Capital expenditures of $50.4M exceeded it, leaving free cash flow of −$69.5M.

Questions

What was Hims & Hers Health's revenue in the second quarter 2025?

Hims & Hers Health (HIMS) reported revenue of $545M for the second quarter 2025 (Q2 2025), +73% from a year earlier and -7% from the quarter before.

Was Hims & Hers Health profitable in the second quarter 2025?

Operating profit was $26.7M (4.9% of revenue) and net earnings $42.5M.

Open the interactive Sankey →

Source: Hims & Hers Health 10-Q on SEC EDGAR.